Veritas Genetics

Veritas Genetics is a personal genomics startup based in Danvers, Massachusetts.[1] It was co-founded in 2014 by George M. Church, Mirza Cifric, Preston Estep, and Jonathan Zhao.[2] Its flagship product, myGenome, aims to provide consumers with information about their genetic risk for disease and allergic reactions based on whole-genome sequencing results. It initially debuted for $999, the first clinical-grade whole genome sequence and interpretation to break the $1000 price barrier.[1][3][4] In the fall of 2018, the company lowered prices to $199 for either the first 1,000 customers to buy one of their kits or for the first two days of the discount. Veritas co-founder and CEO Mirza Cifric said that, by slashing prices dramatically, "We’re sending a clear signal to the medical research community that the $99 genome will be here in three to five years."[5] After this sale ended, the price of myGenome was lowered to $599 in 2019.[6] It was named one of the CNBC Disruptor 50 in 2018[1] and 2019.[7]

Veritas Genetics
Private
IndustryBiotechnology
Personal genomics
Founded2014
FoundersGeorge M. Church
Mirza Cifric
Preston Estep
Jonathan Zhao
Headquarters
Danvers, Massachusetts
,
United States
Key people
Mirza Cifric (CEO)
Preston Estep (Chief Scientific Officer)
ProductsmyGenome
Websitewww.veritasgenetics.com

References
  1. "Veritas Genetics 2018 Disruptor 50". CNBC. 2018-05-22. Retrieved 2019-07-02.
  2. "Why Are We Here?". Veritas Genetics. Retrieved 2019-07-01.
  3. Khan, Razib; Mittelman, David (December 2018). "Consumer genomics will change your life, whether you get tested or not". Genome Biology. 19 (1): 120. doi:10.1186/s13059-018-1506-1. ISSN 1474-760X. PMC 6100720. PMID 30124172.
  4. Regalado, Antonio (2016-03-04). "One DNA Test to Rule Them All". MIT Technology Review. Retrieved 2019-07-02.
  5. Molteni, Megan (2018-11-19). "Now You Can Sequence Your Whole Genome for Just $200". Wired. ISSN 1059-1028. Retrieved 2019-07-02.
  6. Andrews, Joe (2019-07-01). "23andMe competitor Veritas Genetics slashes price of whole genome sequencing 40% to $600". CNBC. Retrieved 2019-07-02.
  7. "Veritas 2019 Disruptor 50". CNBC. 2019-05-15. Retrieved 2019-07-02.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.